Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 740 results for "Ibrutinib"

20 images for Ibrutinib

EurekAlert!, 4 days ago
KXXV-TV, 4 days ago
OncLive, 1 week ago
Lancaster & Morecambe Citizen, 3 weeks ago
Irish Mirror, 3 weeks ago
Monthly Prescribing Reference, 1 month ago
British Journal of Haematology, 1 month ago
MDLinx, 1 month ago
MDLinx, 1 month ago
MDLinx, 1 month ago

FDA Approves New Indication for Ibrutinib in Waldenström's Macroglobulinemia

CancerConnect News : The US Food and Drug Administration (FDA) today expanded the approved use of Imbruvica® (ibrutinib) for patients with Waldenström's macroglobulinemia, a rare type of B-cell lymphoma. Imbruvica® is the first therapy indicated ...
 CancerConnect.com1 week ago FDA Expands Imbruvica Use for Non-Hodgkin Lymphoma  PharmaAsia3 weeks ago Ibrutinib Approved in US for Rare Lymphoma  Dermatology Online Journal1 month ago FDA approves first treatment for rare type of non-Hodgkin's lymphoma  PM 3601 month ago
[x]  
Irish Mirror

New drug hope for blood cancers

A new pill launched in the UK has the potential to transform the treatment of blood cancers, it is claimed. The drug, ibrutinib, is licensed for advanced case patients with two specific types of leukaemia and lymphoma. But its maker, the ...
 Yahoo! UK and Ireland3 weeks ago Blood cancer pill offers fresh hope for thousands of leukaemia sufferers  Irish Mirror3 weeks ago
EurekAlert!

CLL patients discontinue ibrutinib drug due to disease progression during clinical trials

About 10 percent of patients with chronic lymphocytic leukemia (CLL) discontinued therapy with the Bruton tyrosine kinase (BTK) inhibitor drug ibrutinib because of disease progression during clinical trials, according to a study published online in ...
 News-Medical.Net3 days ago Prognosis With Ibrutinib Discontinuation in CLL Identified  Monthly Prescribing Reference4 days ago Researchers Examine Etiology of Ibrutinib Discontinuation in CLL  Physician's Briefing5 days ago Reasons for ibrutinib therapy discontinuation in patients with chronic lymphocytic leukemia  EurekAlert!5 days ago
[x]  
Crawford Financial Planning

Pharmacyclics Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Updates

Key Highlights In the first full year of IMBRUVICA ® (ibrutinib) sales, the Company recorded total revenue of $730 million , driven by U.S. net product revenue of $492 million for the year ended December 31, 2014 , compared to U.S. net product ...
 Morningstar.com1 week ago Bay Area's Pharmacyclics Mulls Possible $18 Billion Sale; Johnson & Johnson,Novartis AG Interested  BioSpace5 days ago Pharmacyclics, Inc. Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Business Updates  BioSpace1 week ago PHARMACYCLICS : Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Business Updates  4 Traders1 week ago
[x]  

Pharmacyclics Announces Update on IMBRUVICA® (ibrutinib) Waldenstrom's macroglobulinemia (WM) Submission

 Financial Content2 months ago Pharmacyclics, Inc. (PCYC) Announces Update On IMBRUVICA® (Ibrutinib) Waldenstrom's Macroglobulinemia (WM) Submission 12/22/2014  ClinicSpace2 months ago Pharmacyclics, Inc. Announces Update On IMBRUVICA?? (Ibrutinib) Waldenstrom's Macroglobulinemia (WM) Submission  BioSpace2 months ago PHARMACYCLICS : Announces Update on IMBRUVICA® (ibrutinib) Waldenstrom's macroglobulinemia (WM) Submission  4 Traders2 months ago
[x]  

The Leukemia & Lymphoma Society Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia

 A.M. Best1 month ago LLS Applauds FDA's Approval of Ibrutinib for Patients with Waldenstrom's Macroglobulinemia  Noodls1 month ago IWMF President Applauds First Approval for Waldenstrom's Macroglobulinemia  CURE Magazine4 weeks ago
[x]  

Ibrutinib's Rise

Pharmacyclics and their reactive kinase inhibitor Imbruvica ( ibrutinib ) have come up a few times around here in the past. (And someone who was involved in its earlier development at Celera shows up here in the comments from time to time). Here's a ...
 Corante5 days ago

FDA approves Johnson & Johnson, Pharmacyclics' Imbruvica for Waldenstrom's macroglobulinaemia

Johnsons & Johnson and Pharmacyclics announced Thursday that the FDA expanded approval of Imbruvica (ibrutinib) to include the treatment of Waldenstrom's macroglobulinaemia. The agency noted that Imbruvica is the first drug authorised to treat the ...
 FirstWord Pharma1 month ago Velcade Approved for Mantle Cell Lymphoma in Europe  American Journal of Managed Care3 weeks ago FDA expands approval of Johnson & Johnson/Pharmacyclics' Imbruvica to Waldenstrom's macroglobulinemia  Pharma Letter1 month ago

First Drug Approved Specifically for Waldenström's Macroglobulinemia

Ibrutinib becomes the first drug specifically approved for Waldenström's macroglobulinemia (WM), two months ahead of expectations. The first drug specifically for Waldenström's macroglobulinemia (WM) was approved by the Food and Drug ...
 CURE Magazine1 month ago First drug to treat Waldenstroms macroglobulinema approved byFDA  Examiner.com4 weeks ago First drug to treat Waldenström's macroglobulinemia approved by FDA  Examiner.com4 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less